Cited by 393Medication Adherence and ComplianceDiabetes Management and EducationDiabetes Treatment and Management

Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database

Open access
Kirkman, M. Sue, Rowan-Martin, Megan T., Levin, Rebecca, Fonseca, Vivian A., Schmittdiel, Julie A., Herman, William H., Aubert, Ronald E.·2015·Diabetes Care

Abstract

OBJECTIVE: Adults with diabetes typically take multiple medications for hyperglycemia, diabetes-associated conditions, and other comorbidities. Medication adherence is associated with improved outcomes, including reduced health care costs, hospitalization, and mortality. We conducted a retrospective analysis of a large pharmacy claims database to examine patient, medication, and prescriber factors associated with adherence to antidiabetic medications. RESEARCH DESIGN AND METHODS: We extracted data on a cohort of >200,000 patients who were treated for diabetes with noninsulin medications in the second half of 2010 and had continuous prescription benefits eligibility through 2011. Adherence was defined as a medication possession ratio ≥0.8. We used a modified adherence measure that accounted for switching therapies. Logistic regression analysis was performed to determine factors independently associated with adherence. RESULTS: Sixty-nine percent of patients were adherent. Adherence was independently associated with older age, male sex, higher education, higher income, use of mail order versus retail pharmacies, primary care versus nonendocrinology specialist prescribers, higher daily total pill burden, and lower out-of-pocket costs. Patients who were new to diabetes therapy were significantly less likely to be adherent. CONCLUSIONS: Several demographic, clinical, and potentially modifiable system-level factors were associated with adherence to antidiabetic medications. Patients typically perceived to be healthy (those who are younger, new to diabetes, and on few other medications) may be at risk for nonadherence. For all patients, efforts to reduce out-of-pocket costs and encourage use of mail order pharmacies may result in higher adherence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-2098

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Male sex was independently associated with greater treatment adherence (OR 1.14, p = 0.0001).

    “In further detail, a study focusing on a variety of factors influencing adherence rates to noninsulin antidiabetic agents indicated that male sex was independently associated with greater treatment adherence (OR 1.14, p = 0.0001) [89].”

    From Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care (2022) · cites this paper as [89]

    The Results (Patient Factors, Table 2) report that men had greater adjusted odds of adherence than women, with an OR of 1.14. The table gives P < 0.0001, not P = 0.0001 as claimed. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • High out-of-pocket drug costs are identified as a factor that limits initiation of and adherence to prescribed glucose lowering therapies.

    “High out-of-pocket (OOP) drug costs are identified as a factor that limit initiation of and adherence to prescribed glucose lowering therapies.8,9,10,11,12”

    From Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease (2023) · cites this paper as [8]

    The Conclusions report that higher out-of-pocket costs were associated with lower odds of adherence to noninsulin antidiabetic medications. They also state that the study could not assess primary nonadherence—failure to fill an initial prescription—so it does not establish that costs limit initiation. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • American Diabetes Association (US)
  • Express Scripts, Franklin Lakes, NJ
  • Tulane University (US)
  • Kaiser Permanente (US)
  • University of Michigan (US)
  • Research and Evaluation Analytics, LLC, Ringwood, NJ
Corresponding author
Kirkman, M. Sue
Venue
Diabetes Care
Published
2015-01-08
Volume
38
Issue
4
Pages
604-609
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2050153005
Cited by
388
References
29
Citations by year
2026: 20 · 2025: 34 · 2024: 37 · 2023: 43 · 2022: 25 · 2021: 54 · 2020: 35 · 2019: 39 · 2018: 28 · 2017: 27 · 2016: 31 · 2015: 15
FWCI
39.31
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Sanofi
  • Novo Nordisk
  • Amylin Pharmaceuticals
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
medication adherence, antidiabetic drugs, diabetes mellitus, medication possession ratio, predictors of adherence, medication burden, out-of-pocket costs, mail-order pharmacy, prescriber specialty, patient demographics, new-onset diabetes
MeSH terms
Assessment of Medication Adherence, Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Insurance Claim Review, Male, Middle Aged, Pharmacies, Retrospective Studies, Epidemiologic Factors, Databases, Factual, Drug Monitoring, Health Care Costs, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review